Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway
出版年份 2015 全文链接
标题
Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 8, Pages 2503-2508
出版商
Proceedings of the National Academy of Sciences
发表日期
2015-02-10
DOI
10.1073/pnas.1424934112
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A New Biology of Diabetes Revealed by Leptin
- (2015) Roger H. Unger et al. Cell Metabolism
- Glycemic Control and Excess Mortality in Type 1 Diabetes
- (2014) Marcus Lind et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early postprandial glucagon surge affects postprandial glucose levels in obese and non-obese patients with type 2 diabetes
- (2013) Junji Kozawa et al. ENDOCRINE JOURNAL
- A Mixed Mirror-image DNA/RNA Aptamer Inhibits Glucagon and Acutely Improves Glucose Tolerance in Models of Type 1 and Type 2 Diabetes
- (2013) Axel Vater et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover
- (2012) Roger H. Unger et al. JOURNAL OF CLINICAL INVESTIGATION
- Iatrogenic hyperinsulinemia in type 1 diabetes: Its effect on atherogenic risk markers
- (2012) May-Yun Wang et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Anti-Diabetic Efficacy and Impact on Amino Acid Metabolism of GRA1, a Novel Small-Molecule Glucagon Receptor Antagonist
- (2012) James Mu et al. PLoS One
- Regulation of Hepatic Glucose Uptake and Storage In Vivo
- (2012) Mary Courtney Moore et al. Advances in Nutrition
- Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats
- (2011) Rachel A. Jamison et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice
- (2011) Y. Lee et al. DIABETES
- Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice
- (2011) J. Mu et al. DIABETOLOGIA
- Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor
- (2010) Wei Gu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Paracrinology of islets and the paracrinopathy of diabetes
- (2010) R. H. Unger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Leptin therapy in insulin-deficient type I diabetes
- (2010) M.-y. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Islet architecture: A comparative study
- (2010) Abraham Kim et al. Islets
- Fibroblast Growth Factor 21 Controls Glycemia via Regulation of Hepatic Glucose Flux and Insulin Sensitivity
- (2009) Eric D. Berglund et al. ENDOCRINOLOGY
- Fully Human Monoclonal Antibodies Antagonizing the Glucagon Receptor Improve Glucose Homeostasis in Mice and Monkeys
- (2009) H. Yan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible -Cell Hyperplasia and Hyperglucagonemia
- (2009) W. Gu et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now